ArticleJournal of neuro-oncology2024

Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.

Camilo E Fadul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.